First Header Logo Second Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Phillips, Gordon
One or more keywords matched the following items that are connected to Phillips, Gordon
Item TypeName
Concept Antineoplastic Combined Chemotherapy Protocols
Academic Article The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Academic Article High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.
Academic Article Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
Academic Article Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Academic Article Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
Academic Article A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
Academic Article Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.
Academic Article Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.
Academic Article A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.
Academic Article A phase I study of decitabine and rapamycin in relapsed/refractory AML.
Academic Article Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.
Search Criteria
  • Antineoplastic Combined Chemotherapy Protocols